Standard therapies for ovarian cancer are derived from plant extracts, or are synthetic chemicals that were developed by pharmaceutical companies. These medications were tested in clinical trials in women with ovarian cancer, and only agents that displayed safety and anti-cancer effects received approval from the United States Food and Drug Administration. Once treatments receive approval, societies of clinical oncologists review the safety and efficacy information, and develop recommended treatment guidelines.